A model of CRC was chosen since it has been shown that ILCs support CRC growth via IL-22 and we wondered whether within this model, PD-1 can increase Tbet+NK1.1− ILCs with a type 1 phenotype. This evidence concerns the gene TBX21 and colorectal carcinoma.